Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols

European Journal of Pharmaceutical Sciences

Volumn 44, Issue 4, 2011, Pages 522-533

  El Gendy, Nashwa ^a,c   Pornputtapitak, Warangkana ^a   Berkland, Cory ^a,b  

^a UNIVERSITY OF KANSAS   (United States)

^b University of Kansas   (United States)

^c Beni Suef University   (Egypt)

Author keywords

Aerosols; Albuterol; Combination therapy; Dry powder; Fluticasone

Indexed keywords

FLUTICASONE PROPIONATE; NANOPARTICLE; SALBUTAMOL SULFATE;

AEROSOL; ARTICLE; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG DETERMINATION; DRUG FORMULATION; DRY POWDER; NANOFABRICATION; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; THERMOGRAVIMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

AEROSOLS; ALBUTEROL; ANDROSTADIENES; BRONCHODILATOR AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMICAL PRECIPITATION; CRYSTALLIZATION; DRUG COMBINATIONS; DRY POWDER INHALERS; LEUCINE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; POWDER DIFFRACTION; POWDERS; RHEOLOGY; SOLUBILITY; SOLVENTS; SOUND; SURFACE-ACTIVE AGENTS; THERMODYNAMICS; THERMOGRAVIMETRY; TRANSITION TEMPERATURE; X-RAY DIFFRACTION;

EID: 80455122800     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.09.014     Document Type: Article

References (48)

1. H. Adi Cospray dried antibiotics for dry powder lung delivery Journal of pharmaceutical sciences 97 2008 3356 3366
2. F. Ahmad Techniques to develop and characterize nanosized formulation for salbutamol sulfate Journal of Materials Science: Materials in Medicine 20 2009 71 76
3. K.L. Aillon Iodinated NanoClusters as an inhaled CT contrast agent for lung visualization Molecular Pharmaceutics 7 2010 1274 1282
4. M.J. Asmus In vitro performance characteristics of valved holding chamber and spacer devices with a fluticasone metered-dose inhaler Pharmacotherapy 24 2004 159 166 (Pubitemid 38209434)
5. M.M. Bailey Pure insulin nanoparticle agglomerates for pulmonary delivery Langmuir 24 2008 13614 13620
6. P. Barnes Scientific rationale for inhaled combination therapy with long-acting 2-agonists and corticosteroids European Respiratory Journal 19 2002 182
7. C. Berkland Next steps for pharmaceutical nanotechnology Journal of Pharmaceutical Innovation 5 2010 70 71
8. U. Bilati Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles European Journal of Pharmaceutical Sciences 24 2005 67 75 (Pubitemid 40051288)
9. H. Chiou Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation International Journal of Pharmaceutics 331 2007 93 98 (Pubitemid 46176506)
10. M.B. Chougule Development of dry powder inhalers Recent Patents on Drug Delivery & Formulation 1 2007 11 21
11. R. Dalby, and J. Suman Inhalation therapy: technological milestones in asthma treatment Advanced drug delivery reviews 55 2003 779 791 (Pubitemid 36776793)
12. N. El-Gendy Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent International Journal of Pharmaceutics 391 2010 305 312
13. N. El-Gendy, and C. Berkland Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration Pharmaceutical research 26 2009 1752 1763
14. N. El-Gendy Agglomerates of ciprofloxacin nanoparticles yield fine dry powder aerosols Journal of Pharmaceutical Innovation 5 2010 79 87
15. N. El Gendy Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution Journal of Pharmaceutical Sciences 98 2009 2731 2746
16. J. Fiegel Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin Pharmaceutical Research 25 2008 805 811 (Pubitemid 351661830)
17. E. Gillian Pilot study of inhaled aerosols targeted via magnetic alignment of high aspect ratio particles in rabbits Journal of Nanomaterials 2010 2011
18. Y. Hadef Thermal stability evaluation of doping compounds before GC-MS analysis by DSC Journal of Thermal Analysis and Calorimetry 93 2008 553 560
19. T. Hu Preparation of inhalable salbutamol sulphate using reactive high gravity controlled precipitation Journal of Pharmaceutical Sciences 97 2008 944 949 (Pubitemid 351293893)
20. W. Kamin Physicochemical compatibility of fluticasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions International Journal of Chronic Obstructive Pulmonary Disease 2 2007 599
21. V. Kumar Compression, compaction, and disintegration properties of low crystallinity celluloses produced using different agitation rates during their regeneration from phosphoric acid solutions AAPS PharmSciTech 2 2001 E7
22. D. Lechuga-Ballesteros Trileucine improves aerosol performance and stability of spray-dried powders for inhalation Journal of Pharmaceutical Sciences 97 2008 287 302
23. M.D. Louey Aerosol dispersion of respirable particles in narrow size distributions using drug-alone and lactose-blend formulations Pharmaceutical Research 21 2004 1207 1213 (Pubitemid 38954205)
24. Y. Michael The physico-chemical properties of salmeterol and fluticasone propionate in different solvent environments International Journal of Pharmaceutics 200 2000 279 288 (Pubitemid 30364915)
25. D. Murnane Crystallization and crystallinity of fluticasone propionate Crystal Growth and Design 8 2008 2753 2764
26. D. Murnane Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals Pharmaceutical research 25 2008 2283 2291
27. H.S. Nelson Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers Journal of allergy and clinical immunology 112 2003 29 36 (Pubitemid 36819803)
28. A. Papi Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma New England Journal of Medicine 356 2007 2040 2052 (Pubitemid 46789894)
29. S. Pham, and T.S. Wiedmann Note: dissolution of aerosol particles of budesonide in Survanta, a model lung surfactant Journal of Pharmaceutical Sciences 90 2001 98 104 (Pubitemid 32050481)
30. G. Pilcer, and K. Amighi Formulation strategy and use of excipients in pulmonary drug delivery International Journal of Pharmaceutics 392 2010 1 19
31. C. Plumley Nifedipine nanoparticle agglomeration as a dry powder aerosol formulation strategy International Journal of Pharmaceutics 369 2009 136 143
32. J. Pritchard The influence of lung deposition on clinical response Journal of Aerosol Medicine 14 2001 19 26
33. S. Rajeswari Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice Virology Journal 3 2006 32 41
34. J. Raula Investigations on the humidity-induced transformations of salbutamol sulphate particles coated with l-leucine Pharmaceutical Research 25 2008 2250 2261
35. M. Rehman Optimisation of powders for pulmonary delivery using supercritical fluid technology European Journal of Pharmaceutical Sciences 22 2004 1 17 (Pubitemid 38543009)
36. S.R. Salpeter Meta-analysis: effect of long-acting-agonists on severe asthma exacerbations and asthma-related deaths Annals of Internal Medicine 144 2006 904
37. L. Shi Biodegradable nanoparticle flocculates for dry powder aerosol formulation Langmuir 23 2007 10897 10901 (Pubitemid 350069300)
38. J. Shur Cospray-dried unfractionated heparin with l-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy Journal of Pharmaceutical Sciences 97 2008 4857 4868
39. H. Steckel, and B.W. Muller Metered-dose inhaler formulation of fluticasone-17-propionate micronized with supercritical carbon dioxide using the alternative propellant HFA-227 International Journal of Pharmaceutics 173 1998 25 33 (Pubitemid 29027757)
40. H. Steckel In vitro characterization of jet-milled and in-situ-micronized fluticasone-17-propionate International Journal of Pharmaceutics 258 2003 65 75 (Pubitemid 36712871)
41. R. Vanbever Sustained release of insulin from insoluble inhaled particles Drug Development Research 48 1999 178 185 (Pubitemid 30115301)
42. A. Vatanara Precipitation of fluticasone propionate microparticles using supercritical antisolvent DARU Journal of Pharmaceutical Sciences 17 2009
43. J.G. Weers Pulmonary formulations: what remains to be done? Journal of Aerosol Medicine and Pulmonary Drug Delivery 23 2010 5 23
44. R. Westmeier, and H. Steckel Combination particles containing salmeterol xinafoate and fluticasone propionate: formulation and aerodynamic assessment Journal of pharmaceutical sciences 97 2008 2299 2310
45. Z. Xu Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate Journal of Pharmaceutical Sciences 99 2010 3398 3414
46. J.Z. Yang Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies Journal of Pharmaceutical Sciences 97 2008 4869 4878
47. Z.Y. Yang Production of ultrafine sumatriptan succinate particles for pulmonary delivery Pharmaceutical Research 25 2008 2012 2018
48. P. Young Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing" Journal of Pharmacy and Pharmacology 54 2002 1339 1344 (Pubitemid 35174178)